Replies to post #67118 on Innovation Pharmaceuticals Inc (IPIX)

[Tails]

More recent :)

From March 2013 CTIX PR


Cellceutix Conducts Research on Retinoblastoma Cancer...

“While our Phase 1 clinical trial is ongoing, we are planning for future trials that are aimed directly at the latest initiatives of the Food and Drug Administration to expedite development of ‘breakthrough’ technologies to commercialization,” commented Dr. Krishna Menon, Chief Scientific Officer at Cellceutix. “The data from the studies affirm that Kevetrin may be useful in a new tumor type, in addition to the other indications that we are studying. Kevetrin has delivered robust results against all indications tested to date. Cellceutix’s strategy is to have multiple trials ongoing against multiple cancer types concurrently. We are conducting testing against several more cancers to delineate the quickest path to market to build corporate and shareholder value.”

- See more at: http://cellceutix.com/cellceutix-plans-for-future-trials-aimed-at-the-latest-initiatives-of-breakthrough-designation-by-the-food-and-drug-administration/#sthash.LlqriMPy.dpuf